What role does CYP2D6 play in Schlaf?

CYP2D6 is a phase I metabolic enzyme involved in the breakdown of many drugs and endogenous compounds. There is no direct evidence that CYP2D6 plays a role in sleep regulation itself. However, its activity can influence the metabolism of medications that affect the central nervous system—such as certain antidepressants, antipsychotics, or beta-blockers—and thereby indirectly impact sleep quality. The classification into 'poor' or 'ultrarapid' metabolizers is clinically relevant for drug dosing but not for natural sleep architecture. Consumer DNA tests like MyBody-X provide only suggestive insights into medication tolerance, not into sleep disorders or patterns. For personal sleep health, factors like light exposure, melatonin, and chronobiology are far more important. Evidence: mechanistic/unclear for direct sleep role.